Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/5/2024 | $41.00 → $45.00 | Neutral → Outperform | Wedbush |
| 5/31/2024 | $37.00 | Outperform | Oppenheimer |
| 10/10/2023 | $32.00 | Neutral → Outperform | Wedbush |
| 8/23/2023 | $36.00 | Neutral → Buy | Sidoti |
| 8/18/2023 | $32.00 | Outperform → Neutral | Wedbush |
| 7/12/2023 | $23.00 → $31.00 | Buy → Neutral | Sidoti |
| 6/28/2023 | $31.00 | Neutral → Outperform | Wedbush |
| 5/10/2022 | $23.00 | Buy | B. Riley Securities |
10-Q - BEAZER HOMES USA INC (0000915840) (Filer)
8-K - BEAZER HOMES USA INC (0000915840) (Filer)
DEF 14A - BEAZER HOMES USA INC (0000915840) (Filer)
Beazer Homes USA, Inc. (NYSE:BZH) (www.beazer.com) announced today the appointment of Lloyd E. Johnson to its Board of Directors. Mr. Johnson brings to the Board 40 years of experience in a variety of leadership roles. He will serve on the Company's Audit Committee and Compensation Committee. From 2004-2015, Mr. Johnson served as Global Managing Director, Finance and Internal Audit, for Accenture Corporation. At Accenture, he was responsible for leading the global consulting company's corporate audit organization and providing guidance and counsel in finance and strategic planning. Prior to joining Accenture, Mr. Johnson was an Executive Director of M&A and General Auditor at Delphi Automo
SC 13G/A - BEAZER HOMES USA INC (0000915840) (Subject)
SC 13G/A - BEAZER HOMES USA INC (0000915840) (Subject)
SC 13G - BEAZER HOMES USA INC (0000915840) (Subject)
Beazer Homes USA, Inc. (NYSE:BZH) (www.beazer.com) today announced its financial results for the three months ended December 31, 2024. "Despite a challenging new home sales environment, we had a productive first quarter and made progress toward our full year and Multi-Year Goals," said Allan P. Merrill, the Company's Chairman and Chief Executive Officer. "Net new orders and closings increased year-over-year, supported by a 20% higher community count. We also grew our total lot position by about 10% versus the prior year, primarily through options, positioning us for further community count growth in the years ahead." Looking to the full fiscal year, Mr. Merrill said, "Despite the afford
Beazer Homes (NYSE:BZH) (www.beazer.com) has scheduled the release of its financial results for the quarter ended December 31, 2024 on Thursday, January 30, 2025 after the close of the market. Management will host a conference call on the same day at 5:00 PM ET to discuss the results. The public may listen to the conference call and view the Company's slide presentation on the "Investor Relations" page of the Company's website, www.beazer.com. In addition, the conference call will be available by telephone at 800-475-0542 (for international callers, dial 630-395-0227). To be admitted to the call, enter the pass code "8571348." A replay of the conference call will be available, until 11:59
Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C
Beazer Homes USA, Inc. (NYSE:BZH) (www.beazer.com) today announced its financial results for the three months ended December 31, 2024. "Despite a challenging new home sales environment, we had a productive first quarter and made progress toward our full year and Multi-Year Goals," said Allan P. Merrill, the Company's Chairman and Chief Executive Officer. "Net new orders and closings increased year-over-year, supported by a 20% higher community count. We also grew our total lot position by about 10% versus the prior year, primarily through options, positioning us for further community count growth in the years ahead." Looking to the full fiscal year, Mr. Merrill said, "Despite the afford
Beazer Homes (NYSE:BZH) (www.beazer.com) has scheduled the release of its financial results for the quarter ended December 31, 2024 on Thursday, January 30, 2025 after the close of the market. Management will host a conference call on the same day at 5:00 PM ET to discuss the results. The public may listen to the conference call and view the Company's slide presentation on the "Investor Relations" page of the Company's website, www.beazer.com. In addition, the conference call will be available by telephone at 800-475-0542 (for international callers, dial 630-395-0227). To be admitted to the call, enter the pass code "8571348." A replay of the conference call will be available, until 11:59
Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C
4 - BEAZER HOMES USA INC (0000915840) (Issuer)
4 - BEAZER HOMES USA INC (0000915840) (Issuer)
4 - BEAZER HOMES USA INC (0000915840) (Issuer)
Wedbush upgraded Beazer Homes from Neutral to Outperform and set a new price target of $45.00 from $41.00 previously
Oppenheimer initiated coverage of Beazer Homes with a rating of Outperform and set a new price target of $37.00
Wedbush upgraded Beazer Homes from Neutral to Outperform and set a new price target of $32.00